Issue of Equity - Dividend Investment Scheme

Summary by AI ^BETAClose X

Maven Income and Growth VCT 3 PLC has issued 192,626 new ordinary shares at 45.98p each under its Dividend Investment Scheme on 15 May 2026. This issuance brings the company's total issued share capital to 156,089,229 ordinary shares, each with one voting right. An application has been made to the London Stock Exchange for these new shares to be admitted to trading, with dealings expected to commence around 20 May 2026.

Disclaimer*

Maven Income and Growth VCT 3 PLC

15 May 2026

Maven Income and Growth VCT 3 PLC

Issue of Equity - Dividend Investment Scheme

The Board of Maven Income and Growth VCT 3 PLC (the Company) confirms that, on 15 May 2026 and under its Dividend Investment Scheme (DIS), the Company issued and allotted 192,626 new ordinary shares of 10p each (Ordinary Shares) at a price of 45.98p per share which, under the Terms and Conditions of the DIS, is equivalent to the latest announced net asset value per share.

As a result, and in accordance with the Financial Conduct Authority's Disclosure, Guidance and Transparency Rules, the Company confirms that its issued share capital as at 15 May 2026 comprises 156,089,229 Ordinary Shares, with each share carrying one voting right. The above figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required, under the Disclosure, Guidance and Transparency Rules, to notify their interest, or a change to their interest, in the Company.

In respect of this allotment, an application will be made by the Company to the London Stock Exchange for the new Ordinary Shares to be admitted to trading on the London Stock Exchange's main market for listed securities. It is expected that the admission of the new Ordinary Shares will become effective, and dealings will commence, on or around 20 May 2026.

Issued on behalf of the Board

Maven Capital Partners UK LLP

Secretary

15 May 2026

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END